Best Stocks to Invest $50,000 Right Now

However, if you have $50,000 to hand, you already possess a solid opportunity to broaden your portfolio and attain substantial returns.

Nevertheless, with such a significant sum at risk, it’s crucial to be meticulous in your selection. This is why, in this article, we will investigate an assortment of stocks from a range of sectors, balancing both growth potential and risk to aid you in optimizing your investment.

What are the best stocks to invest $50,000 right now? Iqvia (IQV), The Mosaic Company (MOS), EPAM Systems (EPAM), Endava (DAVA), and Moderna (MRNA) are leading candidates.

IQVIA Holdings Inc. (IQV)

The healthcare analytics industry is at the forefront of today’s data-driven world, playing a pivotal role in improving patient outcomes and facilitating the revolution in personalized medicine.

Having carved out a significant competitive advantage in the space, IQVIA Holdings is now seen as a sector titan. Indeed, with its vast trove of health-related information serving as both a distinguishing asset and a significant barrier to entry for competitors, IQV benefits from having an unassailable position in this growing market.

However, despite its share price remaining flat over the past year, IQVIA’s recent financial performance has exhibited a promising trend. The firm reported increased year-on-year revenues of $3.65 billion for the first quarter of 2023, with a sector-busting EBITDA margin of 17.6% and a return on total capital of 6.01%.

The Mosaic Company (MOS)

As the world’s leading integrated producer of concentrated phosphate and potash, The Mosaic Company’s unique position in the Fertilizer and Agricultural Chemicals industry has allowed it to operate strategically placed production assets that boast long-lived reserves.

True to form, this approach has helped Mosaic generate revenues of $19.1 billion in 2022, while net income also experienced significant growth, with an increase of 120% ​​at $3.6 billion.

Moreover, the company’s extensive distribution network ensures timely product delivery, fulfilling customers’ needs in a responsible and sustainable manner​​.

In addition, through partnerships such as the Ma’aden Wa’ad Al Shamal Phosphate Company joint venture in Saudi Arabia, Mosaic likewise ensures low-cost phosphate production with proximity to Asian croplands, further solidifying its global footprint​​.

With an enviable history of corporate citizenship and a mission to help the world grow the food it needs, Mosaic has returned $608 million to shareholders in buybacks and dividends, making it an attractive prospect for income investors especially​.

EPAM Systems, Inc. (EPAM)

EPAM Systems, Inc. is a Pennsylvania-based digital transformation services and product engineering company. The firm has a solid track record of customer retention and satisfaction, and its robust “Engineering DNA” has established the enterprise as a specialized digital transformation services provider.

In fact, EPAM has been recognized multiple times for its exceptional performance, including its inclusion in the S&P 500 and Forbes Global 2000 companies, as well as being named a top IT services company on Fortune’s 100 Fastest Growing Companies list multiple times​​.

However, EPAM recently adjusted its financial outlook for Q2 and the full year of 2023 due to an “uneven improvement in demand.” This reduction is largely attributed to clients becoming more cautious with spending in the ‘build’ segment of the global IT services market, causing slower pipeline conversions and a reduction in the total pipeline.

Nonetheless, the company has seen an increasing pace of new logo acquisition and maintains high customer retention and satisfaction rates. The company’s CEO, Arkadiy Dobkin, remains optimistic about EPAM’s position for long-term growth once industry demand returns.

Endava plc (DAVA)

Software development company Endava has been turning heads in the investment world for all the right reasons of late.

For example, in the third quarter of fiscal 2023, the business experienced a remarkable 20.3% year-on-year revenue growth and a 14.6% increase in constant currency sales.

Attesting to its excellent performance this year is DAVA’s highly diversified customer base. The firm significantly increased its number of clients contributing over £1 million in revenue to 155, showing a growing demand for its services and the ability to effectively mitigate risk.

But it’s not just the present that looks bright for Endava. The company’s projected revenue for Q4 and the full fiscal year 2023 indicates a continued upward trajectory, with constant currency growth expected between 16.0% and 16.5%.

Endava’s growth strategy doesn’t stop at financial metrics and projections either. The company has been aggressively pursuing partnerships and acquisitions to bolster its standing in the tech world. For example, it recently expanded its partner ecosystem to include Checkout.com and Stripe and has even become a Google Cloud Premier Partner, indicating an ambitious expansion of its business unit.

Moderna, Inc. (MRNA)

Moderna (MRNA) first gained major prominence during the COVID-19 crisis, where its mRNA vaccine played a pivotal role in global immunization efforts.

However, since its peak, Moderna’s revenues have contracted as vaccination rates surged and the immediate demand for its COVID-19 vaccine has decreased. But this demise in its sales figures shouldn’t overshadow the firm’s promising product pipeline.

Indeed, the company’s innovative mRNA technology is not limited to COVID-19, and it is currently developing various vaccines and therapeutics for other diseases, including cancer, cardiovascular disorders, and rare genetic diseases.

This expansive pipeline, backed by the proven effectiveness of their mRNA technology, positions Moderna well for future growth. Consequently, while the company’s current financial metrics seem concerning, its potential suggests it is a good investment for those seeking exposure to a high-growth business in the biotech sector.

#1 Stock For The Next 7 Days

When Financhill publishes its #1 stock, listen up. After all, the #1 stock is the cream of the crop, even when markets crash.

Financhill just revealed its top stock for investors right now... so there's no better time to claim your slice of the pie.

See The #1 Stock Now >>